The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Los, M.
Right arrow Articles by Chlichlia, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Los, M.
Right arrow Articles by Chlichlia, K.
The Journal of Immunology, 1998, 161: 3050-3055.
Copyright © 1998 by The American Association of Immunologists

Human T Cell Leukemia Virus-I (HTLV-I) Tax-Mediated Apoptosis in Activated T Cells Requires an Enhanced Intracellular Prooxidant State1

Marek Los*, Khashayarsha Khazaie{dagger}, Klaus Schulze-Osthoff*, Patrick A. Baeuerle{ddagger}, Volker Schirrmacher{dagger} and Katerina Chlichlia2,{dagger}

* Department of Internal Medicine I, Eberhard-Karls University, Tübingen, Germany; {dagger} Division of Cellular Immunology, Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany; and {ddagger} Tularik Inc., San Francisco, CA 94080


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have shown that an estradiol-dependent activation of human T cell leukemia virus-I Tax leads to the inhibition of cell proliferation and to the induction of apoptosis. The present study demonstrates that a hormone-dependent activation of Tax promotes an enhanced prooxidant state in stably transfected Jurkat cells as measured by changes in the intracellular levels of glutathione and H2O2; these changes are followed by apoptotic cell death. Additional stimulation of the CD3/TCR pathway enhances the oxidative and apoptotic effects. Both Tax-mediated apoptosis and oxidative stress can be potently suppressed by antioxidants, as is seen with the administration of recombinant thioredoxin (adult T cell leukemia-derived factor) or pyrrolidine dithiocarbamate. Hormone-induced Tax activation induces a long-lasting activation of NF-{kappa}B, which is a major target of reactive oxygen intermediates. The long-term exposure of Jurkat cells to hormone eventually results in a selection of cell clones that have lost Tax activity. A subsequent transfection of these apparently "nonresponsive" clones allows the recovery of Tax responses in these cells. Our observations indicate that changes in the intracellular redox status may be a determining factor in Tax-mediated DNA damage, apoptosis, and selection against the long-term expression of Tax function.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Human T cell leukemia virus (HTLV)3 is the only human retrovirus to be causatively associated with human neoplasia. A long-term persistence of HTLV-I leads to the malignant transformation of HTLV-I-infected cells that results in adult T cell leukemia (1, 2, 3). Extensive in vitro passaging of infected human T lymphocytes eventually leads to the appearance of immortalized cells with an activated phenotype. These T cells constitutively express the IL-2R{alpha} subunit, several lymphokines such as IL-4 and IL-6, and a potent radical-scavenging and reducing agent known as adult T cell leukemia-derived factor/human thioredoxin (ADF) (reviewed in 4 .

HTLV-I carries its own potential oncogene, Tax, which has no cellular counterpart (5, 6) and has been implicated in the transforming properties of the virus (reviewed in 7 . Tax protein has been shown to promote the transcriptional transactivation of a wide range of growth-associated genes. In particular, it has been suggested that a Tax-induced expression of the IL-2R{alpha} subunit promotes autocrine stimulation and consequently the transformation of HTLV-I-infected T cells (8, 9, 10, 11). Thus far, however, only a single report has described the immortalization of human T cells through the expression of Tax alone. In this study, the immortalized T cells were particularly sensitive to activation via the CD3/TCR complex; this complex promoted their mitosis under conditions in which IL-2R function was presumably blocked (12).

A previous study using Jurkat T cells expressing a conditional version of Tax, which was generated by the fusion of the Tax protein of HTLV-I and the hormone-binding domain of the human estrogen receptor (ER-Tax), documented an inhibition of proliferation and an induction of apoptotic cell death upon the hormone-dependent activation of Tax (13). Moreover, we were able to demonstrate that caspases mediate Tax-induced apoptotic T cell death and that the CD95-signaling pathway plays a critical role in this Tax-triggered apoptotic process in our recent work using this hormone-inducible system (14). The antiproliferative effects were dependent upon the duration of ER-Tax activity and were significantly enhanced when the CD3/TCR complex was simultaneously activated (13). These observations corroborated the report of apoptotic cell death in Tax-transformed Rat-1 fibroblasts after serum starvation (15). Furthermore, the cooperative action of Tax and CD3 in T cells supports the reported overlap of the mode of action of Tax with the CD28 T cell costimulatory pathway (16).

The transcriptional complex that is activated by CD28 is closely related to NF-{kappa}B. Both play crucial roles in the TCR-independent, cyclosporin A-insensitive pathways of T cell activation. Both are known to respond to reactive oxygen intermediates (ROIs) and to be selectively suppressed by antioxidants (17, 18). Interestingly, the potent activation of NF-{kappa}B by HTLV-I Tax is, at least in transient transfection assays, also blocked by antioxidants (19). Thus, it seems likely that Tax may induce prooxidant conditions. Such redox changes are expected to function in a cooperative manner, with redox changes induced through Ag or mAb stimulation of the CD3/TCR complex and leading to apoptosis in ER-Tax-expressing Jurkat T cells.

To test the above possibilities, we have generated ER-Tax-expressing Jurkat T cells. A hormone-dependent activation of Tax leads to the trans-activation of Tax-responsive promoters in an inducible manner. We report that a hormone-dependent posttranslational induction of ER-Tax leads to rapid changes in the intracellular levels of H2O2 and glutathione (GSH), promoting an intracellular prooxidant state. Concomitant activation of the CD3/TCR pathway exaggerates the oxidative stress and causes DNA fragmentation in live cells. Antioxidants block the Tax-mediated DNA damage. A long-term exposure of the cells to active ER-Tax selects for or renders surviving cells unresponsive to Tax and allows an apparent recovery of the intracellular redox status. These observations indicate that changes in the intracellular redox state may be a determining factor in Tax-mediated DNA damage, apoptosis, and unresponsiveness.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell lines and transfections

Jurkat T cells that had been stably transfected to express ER-Tax or ER-{Delta}Tax fusion constructs were maintained in culture as described previously (13). The ER-Tax construct carried the ligand-binding domain of the human ER at the 5' end of Tax; the ER-{Delta}Tax construct encoded an inactive fusion protein that was missing the first 12 aa of Tax. Transient transfections and chloramphenicol acetyltransferase (CAT) assays were performed by the DEAE-dextran method as described previously (13) using 3 µg of the CAT reporter plasmids p(HTLV-I)LTR-CAT or p(NF-{kappa}B)4-CAT and 1 µg of transactivator (ER-Tax-expressing plasmid) (13). For the induction of Tax activity, cells were treated with 1 µM of the hormone 17ß-estradiol (Sigma, Deisenhofen, Germany). For the stimulation of NF-{kappa}B activity (positive control), cells were incubated with 20 ng/ml of PMA (Sigma) and 1 µg/ml of PHA (Sigma) for 1 h. Recombinant ADF was produced in Escherichia coli and purified as described previously (20).

Electrophoretic mobility shift assay (EMSA)

Total cell extracts were prepared using a high-salt detergent buffer (Totex) as described previously (21). In brief, the cells were harvested by centrifugation; washed once in ice-cold PBS; and resuspended in 4 cell volumes of Totex buffer containing 20 mM HEPES (pH 7.9), 350 mM NaCl, 20% (w/v) glycerol, 1% (w/v) of Nonidet P-40, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 0.5 mM DTT, 0.1% PMSF, and 1% aprotinin. The cell lysate was incubated on ice for 20 min and then centrifuged for 5 min at 13,000 x g at 4°C. The protein content of the supernatant was determined, and equal amounts of protein (10–15 µg) were added to the binding reaction mixture containing 20 µg of BSA (Sigma), 2 µg of poly(dI-dC) (Boehringer, Mannheim, Germany), 2 µl of a buffer (20 mM HEPES (pH 7.9), 20% glycerol, 100 mM KCl, 0.5 mM EDTA, 1% of Nonidet P-40, 2 mM DTT, and 0.1% PMSF), 4 µl of a buffer (20% Ficoll 400, 100 mM HEPES, 300 mM KCl, 10 mM DTT, and 0.1% PMSF), and 10,000 cpm (Cerenkov) of a 32P-labeled NF-{kappa}B oligonucleotide in a final volume of 20 µl. An NF-{kappa}B oligonucleotide with a high-affinity NF-{kappa}B-binding motif (Promega, Heidelberg, Germany) was labeled with [{gamma}-32P]ATP (3000 Ci/mmol; Amersham, Braunschweig, Germany) and T4 polynucleotide kinase (Promega). The reaction mixture was incubated at room temperature for 25 min. Native 4% polyacrylamide gels were run in 45 mM Tris-borate, 1 mM EDTA. NF-{kappa}B-binding activity was determined by the beta-imaging of native gels.

Apoptosis assay

The induction of apoptosis was measured using a modified version of a method that has been described previously (22). Briefly, cells were loaded with 1 µg/ml of Hoechst 33342 (Molecular Probes, Eugene, OR) for 5 min at room temperature and then transferred on ice while protected from light before measurement. After transferring the cells to flow cytometer-compatible tubes, propidium iodide (PI) was added to a final concentration of 0.5 µg/ml. FACS Vantage (Becton Dickinson, Heidelberg, Germany) was used for sample acquisition and data analysis. Hoechst 33342 was excited at 360 nm, and emission was measured at 450 nm. PI was excited at 488 nm, and emission was detected at 610 nm. The cell population that was bright for Hoechst 33342 staining but still negative for PI was considered to be undergoing apoptosis.

Intracellular GSH measurement

The measurement of intracellular GSH was performed according to Rice et al. (23) with modifications. Cells that had been kept in culture medium were loaded with 20 µM of monochlorobimane (MCB) (Molecular Probes) for 10 min at 37°C. The reaction was stopped by the addition of ice- cold PBS. Cells were subsequently harvested, washed through cold FCS followed by two additional washes with cold PBS, and analyzed with a FACS Vantage flow cytometer. The 351- to 364-nm bandpass filter was used for excitation, and emission was detected at 450 nm. Dead cells were excluded by forward/side scatter gating. The mean values of the fluorescence signal from duplicate samples were considered for data analysis.

Fluorescent measurement of intracellular peroxides with 2',7'-dichlorofluorescein diacetate (DCFH)

Intracellular peroxides were measured according to Royall et al. (24). A stock solution of DCFH (10 mM; Molecular Probes) was prepared under nitrogen in DMSO and stored at -20°C. Cells were loaded with 5 µM of DCFH in culture medium at 37°C for 45 min and then placed on ice before measurement. Loaded cells were collected into FACS-compatible tubes, supplemented with PI (1 µg/ml) (Sigma), and measured using a FACScan (Becton Dickinson).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Stably transfected ER-Tax Jurkat cells exhibit hormone-inducible Tax activity

ER-Tax fusion proteins were shown to transactivate several Tax-responsive reporter plasmids in a hormone-dependent manner (13). Here, we generated Jurkat T cells stably expressing inducible Tax (ER-Tax) or an inactive form of Tax (ER-{Delta}Tax). The transactivation potential of the stably transfected, ER-Tax-expressing Jurkat cells was determined in a time-course experiment using (HTLV-I) long terminal repeat (LTR)- and NF-{kappa}B-dependent reporter plasmids. Cells were preincubated for different lengths of time in medium with or without estradiol and then transfected with the Tax-responsive reporter plasmids. The transiently transfected cells were cultivated for another 2 days in the presence or absence of estradiol before CAT reporter gene assays were performed. A hormone-dependent transactivation of the (HTLV-I)LTR- and NF-{kappa}B-controlled promoters was observed in the cells that were cultured for 2 days with estradiol immediately following the transfections (Fig. 1Go, day 0). Comparable increases in CAT activity were detected with cells that had been preincubated with estradiol for 3 days (data not shown) and 7 days before transfection (Fig. 1Go, day -7). Thus, stably transfected ER-Tax Jurkat cells exhibit estradiol-dependent Tax-activity.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 1. Determination of Tax activity in the ER-Tax-expressing Jurkat clone after long-term incubation with the hormone. The ER-Tax cells were preincubated with or without estradiol (E) for the time period indicated. Next, the cells were washed and transfected with the reporter plasmids p(HTLV-I)LTR-CAT (3 µg) (A) or p(NF-{kappa}B)4-CAT (3 µg) (B) and/or the ER-Tax expression plasmid (1 µg) where indicated. After transfection, the transfected cells were maintained for 40 to 48 h in the presence or absence of hormone; a CAT assay was subsequently performed. The CAT assays were scanned and the CAT signal was quantified using Adobe Photoshop (Mountain View, CA). The arbitrary units (x 104) represent the intensity of the spots as measured by the Scan-analysis program. The experiments were performed in triplicate. The bars represent SDs.

 
Long-term exposure to estradiol leads to Tax unresponsiveness

To test the long-term effects of constitutive Tax-activity, cells were preincubated for 30 days with or without estradiol before being transfected with the Tax-responsive plasmids. Preincubating the cells for 30 days with hormone led to unresponsiveness to Tax, which reduced the expression of the (HTLV-I)LTR- and NF-{kappa}B-driven reporter gene plasmids almost to the basal level of uninduced cells (Fig. 1Go, day -30). Cells that had lost responsiveness to Tax due to 1 mo of continuous culture in the presence of estradiol responded to a new transient transfection of exogenous ER-Tax. In these cells, a hormone-dependent transactivation of LTR- and NF-{kappa}B-dependent reporter plasmids could be detected (Fig. 1Go, day -30 plus ER-Tax). Exposing control cells expressing an inactive (truncated) form of Tax (ER-{Delta}Tax) to estradiol for the same time periods did not result in the transactivation of transiently transfected NF-{kappa}B- or LTR-CAT constructs (data not shown).

The DNA-binding activity of NF-{kappa}B was examined by EMSA for different timepoints after the activation of ER-Tax. Treating ER-Tax-expressing Jurkat cells with hormone resulted in a time-dependent, marked increase of the NF-{kappa}B-specific DNA-binding activity for <=5 days (Fig. 2Go). After estradiol treatment of the cells for 5 days, a 50-fold increase of the NF-{kappa}B-specific band compared with control cells was observed. Thus, in contrast to most other activators of NF-{kappa}B, Tax-induced NF-{kappa}B activation is long-lasting and is stable for >=5 days. In agreement with the CAT assays, NF-{kappa}B activation was no longer detected after a prolonged exposure (1 mo) of the cells to hormone (Fig. 2Go). Control ER-{Delta}Tax-expressing cells were not able to induce NF-{kappa}B-binding activity at the various timepoints tested (Fig. 2Go and data not shown).



View larger version (129K):
[in this window]
[in a new window]
 
FIGURE 2. Kinetics of the hormone-inducible Tax-dependent induction of the DNA-binding activity of NF-{kappa}B. The ER-Tax- or ER-{Delta}Tax-expressing Jurkat cells were cultured in the presence of estradiol (E) for the time period indicated (d = days). Cells that had been stimulated with PMA (20 ng/ml) and PHA (1 µg/ml) for 1 h were used as positive controls. Total cell extracts were prepared for each timepoint, and equal amounts of protein were subjected to EMSA using an NF-{kappa}B-specific oligonucleotide. The position of the specific DNA/protein complex is indicated by an arrow. The bands were scanned with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA), and the intensity was analyzed with ImageQuant software (Molecular Dynamics). Fold induction is indicated in each case as compared with control cells that had been incubated in the absence of hormone and adjusted to the lower unspecific band.

 
Tax induces apoptosis that is blocked by antioxidants

We subsequently analyzed the viability of the Jurkat cells that had been exposed to Tax activity or treated with moderate concentrations (1 µg/ml) of anti-CD3 mAb. As shown in Figure 3Go, treating ER-Tax-expressing Jurkat cells with anti-CD3 mAb alone or for 30 h with estradiol alone resulted in little or no changes in apoptosis (DNA fragmentation) as measured by Hoechst 33342 staining. However, the combination of these two stimuli was strongly synergistic, leading to a nearly threefold increase in the total number of cells undergoing apoptosis compared with the background level of spontaneous apoptosis in these cells. While the induction of apoptosis by a combination of anti-CD3 and hormone was already detectable in ER-Tax Jurkat cells at 8 h after treatment, no significant changes in the number of apoptotic cells were observed for <=30 h posttreatment in control ER-{Delta}Tax cells (data not shown). Thus, the apoptosis observed in TCR-stimulated cells could clearly be attributed to Tax activity.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 3. Blocking of Tax and/or anti-CD3-induced apoptosis by antioxidants. Cells expressing ER-Tax were cultured for 30 h with ADF (40 µg/ml) alone, estradiol (E) (1 µM) and ADF, PDTC (5 µM) alone, or PDTC and E as indicated. ADF and PDTC were added 15 min before the addition of hormone. Anti-CD3 mAb stimulation (immobilized at a concentration of 1 µg/ml) was absent (empty bars) or present (filled bars) for the same time period. After 30 h, cells were stained with Hoechst 33342 and PI and analyzed by FACS analysis. Cells that were highly stained with Hoechst 33342 but still negative for PI were considered to be undergoing apoptosis.

 
To investigate the role of the intracellular redox state in Tax-mediated apoptosis, cells were pretreated with antioxidants before hormone and anti-CD3. Thioredoxin (ADF), which is a potent physiologic antioxidative protein that is able to be secreted and taken up by various cells (20, 25, 26), strongly inhibited Tax-induced apoptosis (Fig. 3Go). Pyrrolidine dithiocarbamate (PDTC), which is an iron chelator and radical scavenger, was slightly less effective. In ADF-treated cells, viability was even moderately increased compared with control cells. Thus, antioxidants can block Tax-induced apoptotic cell death.

Tax induces a prooxidant state in T cells

Since antioxidants can prevent Tax-induced apoptosis, we examined whether Tax has an effect on the cellular redox state. Jurkat cells stably expressing a hormone-inducible Tax fusion protein (ER-Tax) were treated for various times with estradiol. Untransfected cells or cells expressing ER-{Delta}Tax were used as controls. The activation of the ER-Tax fusion protein resulted in an immediate (15 min postinduction) drop in the intracellular amount of GSH and in considerably reduced levels within 2 h after Tax activation (Fig. 4Go). A slow recovery of the GSH levels approaching the levels seen for control cells was seen at 5 days after the beginning of estradiol treatment. In contrast, untransfected or control ER-{Delta}Tax Jurkat cells that had been treated with estradiol did not show any decrease in intracellular GSH levels (Fig. 4Go). ER-Tax Jurkat cells that were cultured in the presence of hormone for a prolonged period of time (1 mo) showed normal levels of GSH (data not shown).



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 4. Time-dependent effect of Tax activity on intracellular GSH levels. The kinetics of intracellular GSH content are shown. Inducible ER-Tax fusion protein ({square}) was activated by the addition of 1 µM of estradiol. Untransfected control cells ({blacktriangleup}) and ER-{Delta}Tax-expressing cells ({circ}) were similarly treated. Cells were harvested and analyzed for intracellular GSH content at the indicated time intervals. Next, cells were loaded with MCB and subjected to FACS analysis. The mean values obtained from four independent experiments are shown together with the variation from the mean. The fluorescence intensity of the unstimulated cells is given as 100%.

 
To confirm the above observations, intracellular H2O2 levels were measured at 2 h after ER-Tax or ER-{Delta}Tax Jurkat cells had been treated with hormone. The treatment of ER-Tax Jurkat cells with estradiol led to a marked increase in the intracellular levels of H2O2 and a concomitant decrease of GSH (Fig. 5Go, A and D). The Tax-mediated prooxidant state was inhibited by pretreating the cells with ADF or PDTC (Fig. 5Go, A and D). Thus, the Tax-induced prooxidant state as well as apoptosis can be blocked by antioxidants. These observations indicate that enhanced prooxidant conditions play a crucial role in the induction of T cell apoptosis by HTLV-I Tax.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 5. Effect of Tax and/or CD3/TCR stimulation on intracellular H2O2 and GSH levels. The induction of prooxidant changes after the activation of Tax and/or TCR is shown. Jurkat cells expressing ER-Tax or ER-{Delta}Tax were activated for 2 h with 1 µM of estradiol (E). A, At 15 min before stimulation with the hormone, human recombinant ADF (40 µg/ml) or PDTC (5 µM) was added to the cultures as indicated. B and C, Cells were stimulated with coated anti-CD3 mAb (1 µg/ml) for 2 h and incubated simultaneously with or without hormone as indicated. Cells were loaded with DCFH for 45 min, and H2O2 was measured by FACS. D, At 15 min before stimulation with estradiol, ADF (40 µg/ml) or PDTC (5 µM) was added to the cultures as indicated. Cells were then loaded with MCB, and the GSH level was measured by FACS analysis. The mean values collected from four independent experiments are shown with the variation from the mean. The mean fluorescence intensity of the control was considered to be 100%.

 
Tax and CD3/TCR-mediated signals synergize in inducing a prooxidant state

The CD3/TCR complex and Tax reportedly cooperate in inducing activation-associated events in T cells as well as activation-induced apoptosis (11, 12, 13). Thus, the individual and combined effects of these two independent stimuli on the intracellular redox state of Jurkat T cells were examined. In response to treatment with immobilized anti-CD3 mAb alone, both ER-Tax- or control ER-{Delta}Tax-expressing cells exhibited a comparable increase in the intracellular concentration of H2O2 (Fig. 5Go, B and C). As expected, estradiol alone enhanced the intracellular H2O2 in the ER-Tax cells, while no such increase was seen in the ER-{Delta}Tax Jurkat cells. Treatment with anti-CD3 mAb and estradiol led to an additive enhancement of intracellular H2O2 in ER-Tax Jurkat cells, but no enhancement was observed in the control ER-{Delta}Tax Jurkat cells (Fig. 5Go, B and C). While only transient changes (lasting for a few hours) were observed in the intracellular levels of H2O2 when anti-CD3 mAb was used, the changes that were induced by hormone activation of ER-Tax were sustained and lasted for several days (data not shown). This observation highlights the chronic nature of the activation events that are mediated by Tax in contrast to the transient effects that are seen in response to TCR stimulation.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Our experiments indicate that Jurkat T cells stably expressing ER-Tax exhibit hormone-inducible Tax activity upon a short-term exposure to estradiol. A long-term exposure to hormone (>30 days) leads to an apparent unresponsiveness. The unresponsiveness is not due to changes in the inherent properties of the cells, as a new transfection with ER-Tax was able to reestablish hormone-dependence. One likely explanation is that cells that are defective in Tax activity have a growth advantage and are selected upon the continuous exposure of cultures to hormone. The early and late effects of Tax activation in the Tax-expressing Jurkat cells can be quite different. It has been reported previously that NF-{kappa}B activity could not be detected in the nucleus following a long-term expression of Tax in Jurkat T lymphocytes (27). In this case, the ability of mitogens and cytokines to induce NF-{kappa}B activation was also blocked. It seems that the NF-{kappa}B-signaling pathway was impaired in the latter study, since Tax was active and the induction of other transcription factors, such as Fos and Jun, was unaffected. However, our results suggest a selection against Tax activity following the prolonged activation of this protein rather than a suppression of NF-{kappa}B activation. Taken together, these observations indicate that T cells may not be able to tolerate the intracellular constitutive expression of Tax for prolonged time periods. This intolerance may explain the apparent shut down of Tax expression in HTLV-I-infected leukemic T cells.

Our posttranslational inducible system allowed a careful kinetic analysis both of the Tax-mediated effects and of NF-{kappa}B activation. We have shown previously that one of the early effects of Tax function is activation-induced T cell apoptosis (13). The observations that we report here indicate that HTLV-I Tax mediates oxidative stress, which in turn may subsequently activate NF-{kappa}B, a prooxidant-inducible transcription factor. The activation of NF-{kappa}B has been recently linked to apoptosis. NF-{kappa}B plays either an antiapoptotic or a proapoptotic role, and the role that is chosen may depend upon the cell type, subunit composition, or duration of the NF-{kappa}B response (reviewed in 28 . In our study, apoptotic cell death in Jurkat cells that had been induced by Tax was shown to be accompanied by NF-{kappa}B activation. The duration of Tax stimulation determines the intensity of T cell activation and oxidative stress and the severity of the antiproliferative effect. This finding may be related in part to the persistence of a prooxidative state and to a prolonged activation of NF-{kappa}B. Transactivation and DNA-binding studies revealed that Tax activity induces a long-lasting induction of NF-{kappa}B, rather than a transient one as has been shown for several chemical and physiologic stimuli of NF-{kappa}B (27, 29). The strong NF-{kappa}B activation was entirely due to the induced Tax protein and not to a direct response of the cells to hormone, as control ER-{Delta}Tax-expressing cells did not show any NF-{kappa}B activation after being exposed to estradiol. Therefore, as previously proposed for apoptosis triggered by serum withdrawal (30), the unusually persistent Tax-induced activation of NF-{kappa}B may exert a proapoptotic function in our experimental system.

A short-term hormone induction of ER-Tax in Jurkat cells together with the stimulation of TCR promotes apoptotic cell death (13). The apoptosis-promoting effect of Tax is particularly evident when low concentrations of anti-CD3 are used. Tax is also able to induce apoptosis in Rat-1 fibroblasts, and this apoptosis is blocked by the Bcl-2 protein (15). Interestingly, Bcl-2 has been shown to function in an antioxidant pathway to prevent apoptosis (31). Moreover, intracellular prooxidant conditions reportedly induce apoptosis in several instances (reviewed in 32 . In the present study, we provide evidence that the mediator of apoptosis, Tax, can induce prooxidant conditions in the cell. This is revealed by a decrease in the intracellular GSH level that occurs rapidly (within 15 min) and lasts for several days. The decrease in the intracellular GSH level is accompanied by a Tax-mediated increase of intracellular H2O2 levels. The long-lasting, Tax-induced prooxidant state correlated with the observed apoptosis and NF-{kappa}B activation. Tax-induced NF-{kappa}B activation can be blocked by antioxidants (19). In addition, Tax-induced apoptosis can be prevented by radical scavengers.

The fact that Tax activity induces a prooxidant state in the cell shows that Tax uses common pathways to induce cellular activation and apoptosis. Since ROIs are involved in the induction of CD95 ligand (CD95L) mRNA expression in some cases (33, 34), this involvement could explain the mechanism underlying the Tax-induced up-regulation of CD95L (14). Moreover, it has been recently shown that prooxidant-induced NF-{kappa}B activation may be involved in the transcriptional activation of the CD95L gene (34, 35).

Tax can transactivate the antioxidative stress protein ADF/thioredoxin (36). ADF is a stress-inducible protein that is secreted from cells; this protein plays an essential role in cellular protection against oxidative stress and cell death and is itself induced by various oxidative agents (37).

The present work provides direct evidence for the production of ROIs by Tax and the involvement of these intermediates in Tax-induced apoptotic T cell death. Our findings suggest that changes in the intracellular redox status may be a critical factor in Tax-mediated DNA damage and apoptosis and in the apparent shut down of Tax expression in HTLV-I-infected cells.


    Acknowledgments
 
We thank Profs. Junji Yodoi and Takashi Uchiyama and Drs. Niki Karagianni and Meinrad Busslinger for their advice, interest, and encouragement.


    Footnotes
 
1 This work was supported in part by the Deutsche Forschungsgemeinschaft and the Lady Tata Foundation. Back

2 Address correspondence and reprint requests to Dr. Katerina Chlichlia, Division of Cellular Immunology, Tumor Immunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. E-mail address: Back

3 Abbreviations used in this paper: HTLV, human T cell leukemia virus; ER, estrogen receptor; GSH, glutathione; ADF, adult T cell leukemia-derived factor/human thioredoxin; CAT, chloramphenicol acetyltransferase; PDTC, pyrrolidine dithiocarbamate; EMSA, electrophoretic mobility shift assay; PI, propidium iodide; MCB, monochlorobimane; ROI, reactive oxygen intermediate; DCFH, 2',7'-dichlorofluorescein diacetate; CD95L, CD95 ligand; LTR, long terminal repeat. Back

Received for publication March 12, 1998. Accepted for publication May 19, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476.[Abstract/Free Full Text]
  2. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415.[Abstract/Free Full Text]
  3. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481.[Free Full Text]
  4. Yodoi, J., T. Uchiyama. 1992. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation, and redox regulation. Immunol. Today 13:405.[Medline]
  5. Seiki, M., S. Hattori, Y. Hirayama, M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80:3618.[Abstract/Free Full Text]
  6. Yoshida, M., J. Fujisawa, J. Inoue, M. Seiki. 1986. Mechanism of the gene expression of HTLV-I and its association with ATL. AIDS Res. 1:S71.
  7. Ressler, S., L. M. Connor, S. J. Marriott. 1996. Cellular transformation by human T-cell leukemia virus type I. FEMS Microbiol. Lett. 140:99.[Medline]
  8. Inoue, J., M. Seiki, T. Taniguchi, S. Tsuru, M. Yoshida. 1986. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 5:2883.[Medline]
  9. Yodoi, J., T. Uchiyama. 1986. IL-2 receptor dysfunction and adult T-cell leukemia. Immunol. Rev. 92:135.[Medline]
  10. Cross, S. L., M. B. Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor {alpha}-chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47.[Medline]
  11. Maruyama, M., H. Shibuya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343.[Medline]
  12. Akagi, T., K. Shimotohno. 1993. Proliferative response of Tax1-transduced primary human T-cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 67:1211.[Abstract/Free Full Text]
  13. Chlichlia, K., G. Moldenhauer, P. T. Daniel, M. Busslinger, L. Gazzolo, V. Schirrmacher, K. Khazaie. 1995. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene 10:269.[Medline]
  14. Chlichlia, K., M. Busslinger, M. E. Peter, H. Walczak, P. H. Krammer, V. Schirrmacher, K. Khazaie. 1997. ICE-proteases mediated HTLV-I Tax-induced apoptotic T-cell death. Oncogene 14:2265.[Medline]
  15. Yamada, T., S. Yamaoka, T. Goto, M. Nakai, Y. Tsujimoto, M. Hatanaka. 1994. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the bcl-2 protein. J. Virol. 68:3374.[Abstract/Free Full Text]
  16. McGuire, K. L., V. E. Curtiss, E. L. Larson, W. A. Haseltine. 1993. Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression. J. Virol. 67:1590.[Abstract/Free Full Text]
  17. Los, M., H. Schenk, K. Hexel, P. A. Baeuerle, W. Dröge, K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-{kappa}B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731.[Medline]
  18. Schreck, R., P. Rieber, P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-{kappa}B transcription factor and HIV-1. EMBO J. 10:2247.[Medline]
  19. Schreck, R., R. Grassmann, B. Fleckenstein, P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-{kappa}B by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288.[Abstract/Free Full Text]
  20. Schenk, H., M. Klein, W. Erdbrügger, W. Dröge, K. Schulze-Osthoff. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-{kappa}B and AP-1. Proc. Natl. Acad. Sci. USA 91:1672.[Abstract/Free Full Text]
  21. Baeuerle, P. A., D. Baltimore. 1988. I{kappa}B: a specific inhibitor of the NF-{kappa}B transcription factor. Science 242:540.[Abstract/Free Full Text]
  22. Hardin, J. A., D. H. Sherr, M. DeMaria, P. A. Lopez. 1992. A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J. Immunol. Methods 154:99.[Medline]
  23. Rice, G. C., E. A. Bump, D. C. Shrieve, W. Lee, M. Kovacs. 1986. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res. 46:6105.[Abstract/Free Full Text]
  24. Royall, J. A., H. Ischiropoulos. 1993. Evaluation of 2',7'-dichlorofluorescein and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch. Biochem. Biophys. 302:348.[Medline]
  25. Tagaya, Y., Y. Maeda, A. Mitsui, N. Kondo, H. Matsui, J. Hamuro, J. Brown, K. I. Arai, T. Yokota, H. Wakasugi, J. Yodoi. 1989. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8:757.[Medline]
  26. Wakasugi, N., Y. Tagaya, H. Wakasugi, A. Mitsui, M. Maeda, J. Yodoi, T. Tursz. 1990. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type-I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA 87:8282.[Abstract/Free Full Text]
  27. Ruben, S. M., C. A. Rosen. 1990. Suppression of signals required for activation of transcription factor NF-{kappa}B in cells constitutively expressing HTLV-I Tax protein. New Biol. 2:894.[Medline]
  28. Baichwal, V. R., P. A. Baeuerle. 1997. Apoptosis: activate NF-{kappa}B or die?. Curr. Biol. 7:R94.[Medline]
  29. Sen, R., D. Baltimore. 1986. Inducibility of {kappa} immunoglobulin enhancer-binding protein NF-{kappa}B by a posttranslational mechanism. Cell 47:921.[Medline]
  30. Grimm, S., M. K. A. Bauer, P. A. Baeuerle, K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-{kappa}B is induced upon apoptosis. J. Cell Biol. 134:13.[Abstract/Free Full Text]
  31. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241.[Medline]
  32. Buttke, T. M., P. A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7.[Medline]
  33. Hug, H., S. Strand, A. Grambihler, J. Galle, V. Hack, W. Stremmel, P. H. Krammer, P. R. Galle. 1997. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem. 272:28191.[Abstract/Free Full Text]
  34. Bauer, M. K. A., M. Vogt, M. Los, J. Siegel, S. Wesselborg, K. Schulze-Osthoff. 1997. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273:8048.[Abstract/Free Full Text]
  35. Cui, H., K. Matsui, S. Omura, S. L. Schauer, R. A. Matulka, G. E. Sonenshein, S.-T. Ju. 1997. Proteasome regulation of activation-induced cell death. Proc. Natl. Acad. Sci. USA 94:7515.[Abstract/Free Full Text]
  36. Masutani, H., K. Hirota, T. Sasada, Y. Ueda-Taniguchi, Y. Taniguchi, H. Sono, J. Yodoi. 1996. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin, by HTLV-I Tax. Immunol. Lett. 54:67.[Medline]
  37. Nakamura, H., K. Nakamura, J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351.[Medline]



This article has been cited by other articles:


Home page
BloodHome page
A. Krueger, S. C. Fas, M. Giaisi, M. Bleumink, A. Merling, C. Stumpf, S. Baumann, D. Holtkotte, V. Bosch, P. H. Krammer, et al.
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
Blood, May 15, 2006; 107(10): 3933 - 3939.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Sieburg, A. Tripp, J.-W. Ma, and G. Feuer
Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Tax Oncoproteins Modulate Cell Cycle Progression and Apoptosis
J. Virol., October 1, 2004; 78(19): 10399 - 10409.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Sanchez Alcaraz, P. Kerkhofs, M. Reichert, R. Kettmann, and L. Willems
Involvement of Glutathione as a Mechanism of Indirect Protection against Spontaneous Ex Vivo Apoptosis Associated with Bovine Leukemia Virus
J. Virol., June 15, 2004; 78(12): 6180 - 6189.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Tripp, Y. Liu, M. Sieburg, J. Montalbano, S. Wrzesinski, and G. Feuer
Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro
J. Virol., November 15, 2003; 77(22): 12152 - 12164.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Kawata, Y. Ariumi, and K. Shimotohno
p21Waf1/Cip1/Sdi1 Prevents Apoptosis as Well as Stimulates Growth in Cells Transformed or Immortalized by Human T-Cell Leukemia Virus Type 1-Encoded Tax
J. Virol., July 1, 2003; 77(13): 7291 - 7299.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Los, M. Mozoluk, D. Ferrari, A. Stepczynska, C. Stroh, A. Renz, Z. Herceg, Z.-Q. Wang, and K. Schulze-Osthoff
Activation and Caspase-mediated Inhibition of PARP: A Molecular Switch between Fibroblast Necrosis and Apoptosis in Death Receptor Signaling
Mol. Biol. Cell, March 1, 2002; 13(3): 978 - 988.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. E. Tome, A. F. Baker, G. Powis, C. M. Payne, and M. M. Briehl
Catalase-overexpressing Thymocytes Are Resistant to Glucocorticoid-induced Apoptosis and Exhibit Increased Net Tumor Growth
Cancer Res., March 1, 2001; 61(6): 2766 - 2773.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
C. Nicot and R. Harrod
Distinct p300-Responsive Mechanisms Promote Caspase-Dependent Apoptosis by Human T-Cell Lymphotropic Virus Type 1 Tax Protein
Mol. Cell. Biol., November 15, 2000; 20(22): 8580 - 8589.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S.-i. Wakamatsu, M. Makino, C. Tei, and M. Baba
Monocyte-Driven Activation-Induced Apoptotic Cell Death of Human T-Lymphotropic Virus Type I-Infected T Cells
J. Immunol., October 1, 1999; 163(7): 3914 - 3919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Rivera-Walsh, M. Waterfield, G. Xiao, A. Fong, and S.-C. Sun
NF-kappa B Signaling Pathway Governs TRAIL Gene Expression and Human T-cell Leukemia Virus-I Tax-induced T-cell Death
J. Biol. Chem., October 26, 2001; 276(44): 40385 - 40388.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Los, M.
Right arrow Articles by Chlichlia, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Los, M.
Right arrow Articles by Chlichlia, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS